CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 6 incoming connections
- ScaleMarket cap is $5.86B, above the global median of $1.15B
- PositionProfit margin is 29.4%, higher than 95% of its Diagnostics & Research peers (median 4.5%)
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.23%Below 5Y avg (0.79%)
Annual Rate
CNY 0.12Paid annual
Payout Ratio
4.5%Sustainable
Last Ex-Dividend
Jun 30, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
39.39BCNY5.86B · vs all stocks (USD)
Trailing P/E
77.34xvs Diagnostics & Research peers
Revenue (TTM)
1.69BCNY250.79M · vs all stocks (USD)
Profit Margin
29.36%vs Diagnostics & Research peers
Beta
0.8150xvs all stocks
52-Week Change
68.49%vs all stocks
Market Capitalization
39.39BCNY5.86B · vs all stocks (USD)
Enterprise Value
37.11BCNY5.52B · vs all stocks (USD)
Trailing P/E
77.34xvs Diagnostics & Research peers
Forward P/E
197.49xvs Diagnostics & Research peers
Price to Sales (TTM)
23.03xvs Diagnostics & Research peers
Price to Book (MRQ)
4.51xvs Diagnostics & Research peers
Enterprise to Revenue
22.00xvs Diagnostics & Research peers
Gross Margin
20.49%vs Diagnostics & Research peers
Profit Margin
29.36%vs Diagnostics & Research peers
Operating Margin
-9.74%vs Diagnostics & Research peers
Return on Assets (TTM)
-1.00%vs Diagnostics & Research peers
Return on Equity (TTM)
5.94%vs Diagnostics & Research peers
Revenue (TTM)
1.69BCNY250.79M · vs all stocks (USD)
Revenue per Share (TTM)
2.33CNYUpdated Aug 21, 2026Quarterly Revenue Growth
10.00%vs Diagnostics & Research peers
Gross Profit (TTM)
264.04MCNY39.27M · vs all stocks (USD)
EBITDA (TTM)
187.94MCNY27.95M · vs all stocks (USD)
Net Income (TTM)
495.08MCNY73.62M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
479.70%vs Diagnostics & Research peers
Operating Cash Flow (TTM)
507.03MCNY75.40M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-254.15MCNY-37.80M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.1200CNYUpdated Aug 21, 2026Trailing Annual Dividend Yield
0.23%vs all stocks
5-Year Average Dividend Yield
0.79%vs all stocks
Payout Ratio
4.48%vs Diagnostics & Research peers
Minority Interest (Equity)
371.15KCNYFY2025 · Dec 31, 2025Revenue
1.66BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
1.31BCNYFY2025 · Dec 31, 2025Gross Profit
343.31MCNYFY2025 · Dec 31, 2025Operating Income
-42.12MCNY-6.26M · vs all stocks (USD)
Pre-tax Income
337.49MCNYFY2025 · Dec 31, 2025Income Tax Expense
39.65MCNYFY2025 · Dec 31, 2025Net Income
297.84MCNYFY2025 · Dec 31, 2025EBIT
338.91MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
187.94MCNYFY2025 · Dec 31, 2025Research & Development
87.43MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
120.09MCNYFY2025 · Dec 31, 2025Other Operating Expenses
9.10MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
78.19MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
1.42MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.4000CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.4000CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
744.60MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
744.60MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
297.84MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-1.48KCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
544.87MCNYFY2025 · Dec 31, 2025Free Cash Flow
402.63MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
911.85MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
297.84MCNYFY2025 · Dec 31, 2025Other Non-cash Items
-29.91MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
62.30MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
214.64MCNYFY2025 · Dec 31, 2025Capital Expenditures
-142.24MCNYFY2025 · Dec 31, 2025Purchase of Investments
-2.65BCNYFY2025 · Dec 31, 2025Sale of Investments
2.35BCNYFY2025 · Dec 31, 2025Other Investing Activity
17.79MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-419.19MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-22.39MCNYFY2025 · Dec 31, 2025Other Financing Charges
-44.60MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-66.98MCNYFY2025 · Dec 31, 2025Shares Outstanding
749.35MSharesUpdated Aug 21, 2026Float Shares
490.90MSharesUpdated Aug 21, 2026% Held by Insiders
39.66%vs all stocks
% Held by Institutions
12.57%vs all stocks
Total Cash (MRQ)
3.08BCNY457.98M · vs all stocks (USD)
Total Cash per Share (MRQ)
4.13CNYUpdated Aug 21, 2026Total Debt (MRQ)
37.00MCNY5.50M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0043xvs Diagnostics & Research peers
Current Ratio (MRQ)
4.02xvs Diagnostics & Research peers
Book Value per Share (MRQ)
11.49CNYUpdated Aug 21, 2026Total Assets
9.68BCNY1.44B · vs all stocks (USD)
Total Current Assets
5.26BCNYFY2025 · Dec 31, 2025Total Liabilities
1.36BCNYFY2025 · Dec 31, 2025Total Non-current Assets
4.42BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
195.97MCNYFY2025 · Dec 31, 2025Total Current Liabilities
1.16BCNYFY2025 · Dec 31, 2025Cash
858.76MCNYFY2025 · Dec 31, 2025Cash Equivalents
53.09MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
911.85MCNYFY2025 · Dec 31, 2025Other Short-term Investments
1.72BCNYFY2025 · Dec 31, 2025Accounts Receivable
181.13MCNYFY2025 · Dec 31, 2025Inventory
1.41BCNYFY2025 · Dec 31, 2025Accounts Payable
73.96MCNYFY2025 · Dec 31, 2025Short-term Debt
20.17MCNYFY2025 · Dec 31, 2025Other Current Liabilities
3.84MCNYFY2025 · Dec 31, 2025Long-term Debt
1.42MCNYFY2025 · Dec 31, 2025Common Stock (Book)
749.48MCNYFY2025 · Dec 31, 2025Retained Earnings
2.37BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
8.33BCNY1.24B · vs all stocks (USD)
Treasury Stock
230.57MCNYFY2025 · Dec 31, 202552-Week Low
26.25CNYUpdated Aug 21, 202652-Week High
55.68CNYUpdated Aug 21, 202652-Week Change
68.49%vs all stocks
Beta
0.8150xvs all stocks
50-Day MA
42.83CNYUpdated Aug 21, 2026200-Day MA
37.27CNYUpdated Aug 21, 2026Avg 10-Day Volume
50.88MSharesUpdated Aug 21, 2026Avg 30-Day Volume
58.12MSharesUpdated Aug 21, 2026Diluted EPS (TTM)
0.6700CNYUpdated Aug 21, 20262 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Multi-Year Debt Decrease With Cash Near Total Debt And Equity
Long-term debt down in each of four years, and cash now covers most or all of what is left.
Reads
How does this company use capital?
Cash-Flow Ratios Elevated
More of its sales turn into cash than in its industry, and less of that cash is consumed by reinvestment than at most of its peers.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Profit margin is 29.4%, higher than 95% of its Diagnostics & Research peers (median 4.5%)Significant
Profit margin: 0.29Industry median: 0.05Industry P95: 0.23Peers compared: 28.00
Debt-to-equity is 0×, lower than 95% of its Diagnostics & Research peers (median 0.3×)Notable
Debt-to-equity: 0.00Industry median: 0.30Industry P5: 0.02Peers compared: 28.00
Supply Chain
Midstream position: 6 outgoing, 6 incoming connectionsNotable
Outgoing: 6.00Incoming: 6.00
High connectivity hub: 12 industry connectionsNotable
Total Connections: 12.00
Scale
Market cap is $5.86B, above the global median of $1.15BNotable
Market cap (USD): 5,858,168,114.407Global Median: 1,146,734,693.424
Companies that share the same coordination system — how they create, deliver, or capture value.
Shandong Sun Paper Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
SmartSens Technology (Shanghai) Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Ford Otomotiv Sanayi A.Ş.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Fujian Wanchen Biotechnology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingFlow
Twist Bioscience Corporation
Tier 1ProductionThroughput-Bound ConversionFlowRule
ASR Microelectronics Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Hankook Tire & Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Acm Research Inc.
Tier 1ProductionThroughput-Bound ConversionSenseMakingFlow
Iteq Corporation
Tier 1ProductionThroughput-Bound ConversionFlowRule
QuantumCTek Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Harmony Biosciences Holdings, Inc.
2 interpretationsCash-Flow Ratios ElevatedMulti-Year Debt Decrease With Cash Near Total Debt And Equity
Suzhou Sepax Technologies Inc.
2 interpretationsCash-Flow Ratios ElevatedMulti-Year Debt Decrease With Cash Near Total Debt And Equity
Infund Holding Co. Ltd.
1 interpretationCash-Flow Ratios Elevated